Our CEO, @BethJHoffman shares some perspectives on how the work at Origami Therapeutics applies to improving brain healthspan in the latest issue of @LongevityTech https://t.co/qrzNdZjrMW
ReVision Implant gets FDA Breakthrough Device nod for neural interface designed to restore vision by directly stimulating the visual cortex.
https://t.co/Dcl6QIXlDK
#longevity#visionloss#neurotech#bionics
Company targets regulatory submission and commercialization of non-invasive treatment platform, currently in pivotal human trials.
https://t.co/ojdonhQwYE
#longevity#investment#neurotech#alzheimers#brain
Vesalic CEO on targeting neurodegenerative disease ‘upstream’ after discovering a metabolic dysfunction in the blood of ALS patients.
https://t.co/zwge38D5sS
#longevity#biotech#ALS#MND#neurodegeneration